January 2026
The global allogeneic cell therapy devices market size is projected to hit around USD 4,565.79 million by 2035 from USD 511.30 million in 2025 with a CAGR of 24.48%.
September 2026
The global personalized cell therapy market size was evaluated at USD 46.06 billion in 2026 and is predicted to reach around USD 235.65 billion by 2034, with a CAGR of 22.81%.
September 2026
The global radiotherapy monitoring devices market size is estimated to hit around USD 2.48 billion by 2035 increasing from USD 1.29 billion in 2025, with a CAGR of 6.74%.
September 2026
The cell and gene therapy manufacturing market size is predicted to hit around USD 122.86 billion by 2034 from USD 18.06 billion in 2026, with a CAGR of 26.62%.
September 2026
The global cell and gene therapy bioanalytical testing services market size is expected to hit around USD 1,113.86 million by 2034 from USD 632.03 million in 2026, with a CAGR of 7.34%.
September 2026
The automation, digitization and robotics in cell and gene therapy manufacturing market reached USD 1,127.65 million in 2026, with key automation, digitization and robotics in cell and gene therapy manufacturing market companies including Thermo Fisher Scientific Inc., Sartorius AG, Danaher Corporation (Cytiva), Lonza Group AG.
September 2026
The U.S. cell therapy manufacturing market was worth USD 1.97 billion in 2026, with key U.S. cell therapy manufacturing market players including Merck KGaA, Thermo Fisher Scientific, Catalent, Inc.
September 2026
The stem cell therapy for neurological disorders market generated USD 17.90 billion in 2026, with prominent stem cell therapy for neurological disorders market companies including BrainStorm Cell Therapeutics, Mesoblast, ReNeuron Group.
September 2026
The U.S. CAR T-cell therapy market size stood at USD 2,684.84 million in 2026, with major U.S. CAR T-cell therapy market companies including Bristol-Myers Squibb Company, Novartis AG, Gilead Sciences, Inc.
September 2026
The US cell and gene therapy market generated USD 4.74 billion in 2026, with prominent US cell and gene therapy market companies including Alnylam Pharmaceuticals Inc., Amgen Inc., Biogen Inc., CORESTEM Inc.
August 2026
The cell therapy market size reached USD 9.13 billion in 2026, with leading cell therapy market companies including cell therapy , Cells for Cells, Celgene Corporation.
August 2026
The global cell and gene therapy clinical trials market size is projected to hit around USD 54.29 billion by 2034 from USD 13.32 billion in 2024 with a CAGR of 15.09%
July 2026
The global CAR T-cell therapy market size is calculated at USD 5,206.15 million in 2025 and is projected to surpass around USD 26,982.3 million by 2035 with a solid CAGR of 17.88%.
July 2026
The cell and gene therapy market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
July 2026
The cell and gene therapy patient access and reimbursement market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries..
July 2026
The stem cell therapy market size is expected to increase from USD 18.13 billion in 2025 and it is predicted to hit USD 59.70 billion by 2035 at a CAGR of 12.66%.
June 2026
The global induced pluripotent stem cell (iPSC) therapy market is driven by rising chronic disease prevalence, personalized medicine demand, and advances in regenerative technology.
June 2026
The global engineered TCR (T-Cell Receptor) therapy market is growing as immunotherapies advance for cancer and infectious disease treatment.
June 2026
The global cell and gene therapy quality control and analytics market is expanding with growing demand for robust testing, validation, and compliance in advanced therapies.
June 2026
The global T-cell immunotherapy market size is estimated to hit around USD 29.45 billion by 2035 increasing from USD 8.43 billion in 2025, with a CAGR of 13.33%.
June 2026
The global cell therapy manufacturing market size was valued at USD 5.55 billion in 2025 and is projected to hit around USD 21.02 billion by 2035 with a CAGR of 14.24%.
June 2026
The U.S. stem cell therapy market size reached USD 6.75 billion in 2025 and is projected to hit around USD 21.31 billion by 2035 with a remarkeble CAGR of 12.18%.
May 2026
The global automated and closed cell therapy market size is estimated to hit around USD 12.9 billion by 2035 increasing from USD 1.86 billion in 2025, with a CAGR of 21.37%.
April 2026
The autologous cell therapy market size was garnered at USD 11.43 billion in 2025 and is expected to hit around USD 60.03 billion by 2035 With a CAGR of 18.04%.
April 2026
The global cell and gene therapy market size was calculated at USD 8.94 billion in 2025 and is projected to surpass around USD 47.18 billion by 2035 with a solid CAGR of 18.1%.
February 2026
The global T-cell therapy market size is reached at USD 10.30 billion in 2025 and it is expected to hit around USD 196.21 billion by 2035 with a CAGR of 34.27%.
December 2025
The global automated and closed cell therapy processing system market size is expected to hit around USD 14.46 billion by 2035 with a CAGR of 22.76%.
July 2025
The global cell and gene therapy CDMO market size is estimated to hit around USD 74.03 billion by 2034 increasing from USD 10.33 billion in 2026, with a CAGR of 27.92%.
July 2025
The global B-cell lymphoma market size was evaluated at USD 5.08 billion in 2024 and is predicted to hit around USD 10 billion by 2034, growing at a CAGR of 7.00%.
September 2026
The global ambulatory cardiac monitoring devices market size is estimated to hit around USD 24.58 billion by 2035 increasing from USD 9.47 billion in 2026, with a CAGR of 11.19%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com